This page is for informational purposes only
Reduced Contamination Risk: By using TB500 BPC157 20mg Pre Mixed Pen, the risk of contamination is minimised, ensuring the integrity of the peptides for research purposes
Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial
Detachable-needle setups may use a Luer-lock or Luer-slip syringe
It stabilizes intestinal permeability and enhances cytoprotection, making it a promising candidate for mitigating NSAID-induced gastroenteropathy and leaky gut syndrome
Alone, research supports each ingredient for focus and cognition, and it makes sense to provide them in separate containers